Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450

Spreading of the multidrug-resistant (MDR) strains of the one of the most harmful pathogen Mycobacterium tuberculosis (Mtb) generates the need for new effective drugs. SQ109 showed activity against resistant Mtb and already advanced to Phase II/III clinical trials. Fast SQ109 degradation is attribut...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Mol Sci
Egile Nagusiak: Bukhdruker, Sergey, Varaksa, Tatsiana, Grabovec, Irina, Marin, Egor, Shabunya, Polina, Kadukova, Maria, Grudinin, Sergei, Kavaleuski, Anton, Gusach, Anastasiia, Gilep, Andrei, Borshchevskiy, Valentin, Strushkevich, Natallia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589583/
https://ncbi.nlm.nih.gov/pubmed/33081390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21207683
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak